Potential role of pimecrolimus as maintenance therapy for atopic dermatitis

被引：0
|
作者：
Eichenfield, L
Leung, DYM
机构：
[1] Univ Calif San Diego, Childrens Hosp, San Diego, CA 92103 USA
[2] Univ Calif San Diego, Ctr Hlth, San Diego, CA 92103 USA
[3] Natl Jewish Med & Res Ctr, Denver, CO USA
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2002年 / 109卷 / 01期
关键词：
D O I：
10.1016/S0091-6749(02)81917-0
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
782
引用
收藏
页码：S256 / S256
页数：1
相关论文
共 50 条
  • [31] Potential Role of IL-37 in Atopic Dermatitis
    Mesjasz, Alicja
    Trzeciak, Magdalena
    Glen, Jolanta
    Jaskulak, Marta
    CELLS, 2023, 12 (23)
  • [32] The Potential Role of Impaired Notch Signalling in Atopic Dermatitis
    Melnik, Bodo C.
    ACTA DERMATO-VENEREOLOGICA, 2015, 95 (01) : 5 - 11
  • [33] Potential Role of Endothelin-1 in Atopic Dermatitis
    Nakahara, Takeshi
    Kido-Nakahara, Makiko
    Furue, Masutaka
    CURRENT TREATMENT OPTIONS IN ALLERGY, 2019, 6 (02) : 156 - 163
  • [34] Efficacy and tolerance of tacrolimus and pimecrolimus for atopic dermatitis: a meta-analysis
    Yin, Zhiqiang
    Xu, Jiali
    Luo, Dan
    JOURNAL OF BIOMEDICAL RESEARCH, 2011, 25 (06): : 385 - 391
  • [35] Australian cost-utility analysis of crisaborole and pimecrolimus for atopic dermatitis
    Chen, Michelle
    Sebaratnam, Deshan
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2022, 63 : 27 - 27
  • [36] Pimecrolimus in atopic dermatitis: Consensus on safety and the need to allow use in infants
    Luger, Thomas
    Boguniewicz, Mark
    Carr, Warner
    Cork, Michael
    Deleuran, Mette
    Eichenfield, Lawrence
    Eigenmann, Philippe
    Foelster-Holst, Regina
    Gelmetti, Carlo
    Gollnick, Harald
    Hamelmann, Eckard
    Hebert, Adelaide A.
    Muraro, Antonella
    Oranje, Arnold P.
    Paller, Amy S.
    Paul, Carle
    Puig, Luis
    Ring, Johannes
    Siegfried, Elaine
    Spergel, Jonathan M.
    Stingl, Georg
    Taieb, Alain
    Torrelo, Antonio
    Werfel, Thomas
    Wahn, Ulrich
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2015, 26 (04) : 306 - 315
  • [37] Pimecrolimus but not betamethasone sustains elevated antimicrobial protein expression in atopic dermatitis
    Jensen, J.
    Glaeser, R.
    Koehler, B.
    Harder, J.
    Braeutigam, M.
    Schwarz, T.
    Proksch, E.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2008, 128 : S182 - S182
  • [38] Management of Patients with Atopic Dermatitis: The Role of Emollient Therapy
    Correa, M. Catherine Mack
    Nebus, Judith
    DERMATOLOGY RESEARCH AND PRACTICE, 2012, 2012
  • [39] Atopic dermatitis: The role of recombinant interferon-γ therapy
    Chang T.T.
    Stevens S.R.
    American Journal of Clinical Dermatology, 2002, 3 (3) : 175 - 183
  • [40] Duration of topical therapy in the maintenance of atopic dermatitis remission in pediatric age
    Pecoraro, Luca
    Florile, Marta
    Piazza, Michele
    Comberiati, Pasquale
    Clemente, Maria
    Tadiotto, Elisa
    Pietrobelli, Angelo
    Piacentini, Giorgio
    MINERVA PEDIATRICS, 2021, 73 (04): : 294 - 300
12345